RCA
BIIB icon

Rex Capital Advisors’s Biogen BIIB Stock Holding History

Rex Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-840
Closed -$263K – 20
2017
Q3 		$263K Buy
840
+17
+2% +$5.03K 0.21% 29
2017
Q2 		$223K Buy
823
+79
+11% +$20.9K 0.19% 29
2017
Q1 		$203K Buy
+744
New +$210K 0.18% 32

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Rex Capital Advisors's BIIB Position: Q4 2017 in Review

Rex Capital Advisors sold out of Biogen (BIIB) in Q4 2017, closing a stake of 840 shares — an estimated $263K sold.

Rex Capital Advisors first reported a position in BIIB in Q1 2017 and held it in 3 quarters. The position peaked at $263K in Q3 2017. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Rex Capital Advisors reported no remaining Biogen position as of Q4 2017 after selling out during the quarter.
  • Rex Capital Advisors sold 840 Biogen shares in Q4 2017, an estimated $263K.
  • Rex Capital Advisors first reported a position in Biogen in Q1 2017 and held it in 3 quarters.
  • Rex Capital Advisors's Biogen position peaked at $263K in Q3 2017.
  • 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Rex Capital Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.